Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 4:04 PM ET


Company Overview of Iroko Pharmaceuticals, LLC

Executive Profile

Louis Vollmer

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Mr. Louis Vollmer served as an Executive of Endo Pharmaceuticals Holdings Inc. Mr. Vollmer is a Senior Pharmaceutical Industry Executive, with experience in chemistry and business. He was a Co-Founder of DuPont Pharmaceutical's generics business and one of the partners responsible for the subsequent $300 million management buy-out of that and other related businesses which eventually became Endo Pharmaceuticals Inc. As the Founding Executive Vice President of Sales and ...

Corporate Headquarters

One Kew Place
Philadelphia, Pennsylvania 19112

United States

Phone: 267-546-3003
Fax: 267-546-3004

Board Members Memberships



BA 1978
University of Delaware

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Iroko Pharmaceuticals, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at